PMC:7253235 / 8282-8522 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"267","span":{"begin":62,"end":70},"obj":"Species"},{"id":"272","span":{"begin":150,"end":162},"obj":"Disease"},{"id":"273","span":{"begin":187,"end":210},"obj":"Disease"},{"id":"274","span":{"begin":224,"end":232},"obj":"Disease"}],"attributes":[{"id":"A267","pred":"tao:has_database_id","subj":"267","obj":"Tax:9606"},{"id":"A272","pred":"tao:has_database_id","subj":"272","obj":"MESH:D006973"},{"id":"A273","pred":"tao:has_database_id","subj":"273","obj":"MESH:D002561"},{"id":"A274","pred":"tao:has_database_id","subj":"274","obj":"MESH:D003920"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A meta-analysis of 6 Chinese studies evaluating 1527 affected patients showed that the most prevalent cardiovascular metabolic comorbidities included hypertension (17.1%), cardiac and/or cerebrovascular disease (16.4%), and diabetes (9.7%)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T83","span":{"begin":150,"end":162},"obj":"Disease"},{"id":"T84","span":{"begin":187,"end":210},"obj":"Disease"},{"id":"T85","span":{"begin":224,"end":232},"obj":"Disease"}],"attributes":[{"id":"A83","pred":"mondo_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"},{"id":"A84","pred":"mondo_id","subj":"T84","obj":"http://purl.obolibrary.org/obo/MONDO_0011057"},{"id":"A85","pred":"mondo_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"}],"text":"A meta-analysis of 6 Chinese studies evaluating 1527 affected patients showed that the most prevalent cardiovascular metabolic comorbidities included hypertension (17.1%), cardiac and/or cerebrovascular disease (16.4%), and diabetes (9.7%)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T39","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"A meta-analysis of 6 Chinese studies evaluating 1527 affected patients showed that the most prevalent cardiovascular metabolic comorbidities included hypertension (17.1%), cardiac and/or cerebrovascular disease (16.4%), and diabetes (9.7%)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T55","span":{"begin":150,"end":162},"obj":"Phenotype"}],"attributes":[{"id":"A55","pred":"hp_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/HP_0000822"}],"text":"A meta-analysis of 6 Chinese studies evaluating 1527 affected patients showed that the most prevalent cardiovascular metabolic comorbidities included hypertension (17.1%), cardiac and/or cerebrovascular disease (16.4%), and diabetes (9.7%)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T54","span":{"begin":0,"end":240},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A meta-analysis of 6 Chinese studies evaluating 1527 affected patients showed that the most prevalent cardiovascular metabolic comorbidities included hypertension (17.1%), cardiac and/or cerebrovascular disease (16.4%), and diabetes (9.7%)."}